Information  X 
Enter a valid email address

Kanabo Group PLC (KNB)


Thursday 08 April, 2021

Kanabo Group PLC

Q1 Summary

RNS Number : 8796U
Kanabo Group PLC
08 April 2021

8 April 2021

Kanabo Group PLC

("Kanabo" or the "Company")

Q1 Summary

Kanabo Group Plc, a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, has today published a Q1 summary newsletter, detailing its recently announced agreements and further news on the Company. The Company believes that the past month since listing has been an exciting one, having announced several key steps forward that the Company is taking in order to enable it to deliver value to shareholders. Kanabo expects to continue actively working on partnerships and on strengthening its team, as well as other goals outlined in their newsletter. Details can also be found on news features and upcoming events featuring Kanabo, as well as a discussion of relevant industry news.

Copies of the full newsletter will be available to download from the Company's website at . An email registration facility is also available on the Company's website to directly receive updates.


For further information, please visit or contact the following:

Kanabo Group Plc


[email protected]

Meirav Horn


Peterhouse Capital Limited (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Guy Miller / Allie Feuerlein

Peterhouse Capital Limited (Corporate Broker)

Lucy Williams / Charles Goodfellow


About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted companies to distribute media only / non-regulatory news releases into the public domain.  Information required to be notified under the Listing Rules, Disclosure and Transparency Rules, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t